Application and Effect
Doxazosin mesylate is a new highly selective α1 receptor blockers, having a significant effect of causing reduction in blood pressure while having good effect of alleviating lipid metabolism. It can significantly reduce serum triglycerides and total cholesterol; it can also selectively block the a1 adrenergic receptor of prostate smooth muscle matrix, capsule and bladder neck, alleviating the symptoms of benign prostatic hyperplasia patients, further significantly slowing down the effect of benign prostatic hyperplasia, especially having good effect on the treatment of dysuria caused by simple prostatic hyperplasia. It has a long half-life.There may be dizziness, dry mouth, headache, palpitations, fatigue, the symptoms are mild, bearable, disappear within about 1 week, without special treatment. No postural hypotension occurred.Product Sample
Product Packing:
Additional Information:
| Composition | C24H29N5O8S |
| Assay | 99% |
| Appearance | White powder |
| CAS No. | 77883-43-3 |
| Packing | 25KG |
| Shelf Life | 2 years |
| Storage | Store in cool and dry area |
| Certification | ISO. |